» Articles » PMID: 2872950

Cardiovascular Effects of Non-depolarizing Neuromuscular Blockers in Patients with Coronary Artery Disease

Overview
Specialty Anesthesiology
Date 1986 May 1
PMID 2872950
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

To compare haemodynamic responses associated with equipotent doses of muscle relaxants and high dose fentanyl (50 micrograms X kg-1), 40 non-hypertensive patients who were receiving beta adrenergic and calcium channel blocker therapy and undergoing coronary bypass surgery were randomized to four study groups receiving the following: (1) atracurium: 0.4 mg X kg-1, (2) pancuronium: 0.12 mg X kg-1, (3) vecuronium: 0.12 mg X kg-1, or (4) pancuronium-metocurine mixture: (0.4 mg + 1.6 mg X ml-1):1 ml/10 kg. Neuromuscular blockers were injected with fetanyl at induction. Haemodynamics were recorded with the patients awake (baseline), at two minutes post-induction, and at two and five minutes after intubation. Pancuronium was the only drug associated with significant increases in HR; no other significant changes occurred within each group when compared to their respective baseline haemodynamics. HR increased more after induction with pancuronium when compared to atracurium (23 vs. 4 per cent, p less than 0.05) and to vecuronium (23 vs. 2 per cent, p less than 0.05), and when compared to vecuronium after intubation (29 vs. 7 per cent, p less than 0.05). The pancuronium-metocurine mixture caused tachycardia which was less than, though not significantly different than with pancuronium; however, HR returned to baseline by five minutes with the mixture, but remained elevated with pancuronium (3 vs. 18 per cent, p less than 0.05). SVR fell more on induction with atracurium when compared to vecuronium (-18 vs. 1 per cent, p less than 0.05). These changes in HR or SVR were not accompanied by ECG signs of ischaemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

A comparison of pipecuronium with pancuronium on haemodynamic variables and plasma catecholamines in coronary artery bypass patients.

Neidhart P, Champion P, Vogel J, Zsigmond E, Tassonyi E Can J Anaesth. 1994; 41(6):469-74.

PMID: 8069985 DOI: 10.1007/BF03011539.


Anesthesia and myocardial infarction.

Maille J, Boulanger M, DYRDA I, Trembly N Can Anaesth Soc J. 1986; 33(6):807-19.

PMID: 3536036 DOI: 10.1007/BF03027136.


Pharmacokinetics and cardiovascular dynamics of pipecuronium bromide during coronary artery surgery.

Wierda J, Karliczek G, Vandenbrom R, Pinto I, Meijer D, Agoston S Can J Anaesth. 1990; 37(2):183-91.

PMID: 2155718 DOI: 10.1007/BF03005467.

References
1.
STOELTING R . Blood-pressure responses to d-tubocurarine and its preservatives in anesthetized patients. Anesthesiology. 1971; 35(3):315-7. DOI: 10.1097/00000542-197109000-00016. View

2.
Lienhart A, Guggiari M, Tauvent A, Maneglia R, Cousin M, VIARS P . [Hemodynamic effects of vecuronium in man]. Ann Fr Anesth Reanim. 1983; 2(1):7-16. DOI: 10.1016/s0750-7658(83)80043-4. View

3.
Philbin D, Machaj V, Tomichek R, SCHNEIDER R, Alban J, Lowenstein E . Haemodynamic effects of bolus injections of atracurium in patients with coronary artery disease. Br J Anaesth. 1983; 55 Suppl 1:131S-134S. View

4.
Waller J, HUG Jr C, Nagle D, Craver J . Hemodynamic changes during fentanyl--oxygen anesthesia for aortocoronary bypass operation. Anesthesiology. 1981; 55(3):212-7. DOI: 10.1097/00000542-198109000-00005. View

5.
Miller R, Rupp S, Fisher D, Cronnelly R, Fahey M, Sohn Y . Clinical pharmacology of vecuronium and atracurium. Anesthesiology. 1984; 61(4):444-53. DOI: 10.1097/00000542-198410000-00014. View